For mine, very disappointing this announcement. Sure, it's nice to have another product in development oxymorphone, but oxycodone is the lead product and there's basically more and more delays announced here.
"The Company is preparing to re-enter the clinic to conduct a multi-dose trial with its lead product, oxycodone patch." That means this product is at phase 0 again. Multi-dose trial is phase I, which they didn't even give a timeframe for when it will begin. Phase III seems very far away.
There is also the minor issue of a somewhat decreasing demand for pure oxycodone due to increasing use of targin (oxycodone/naloxone) which I'm witnessing (I'm a doctor). It has significant benefits of less constipation. An opioid patch (eg. Fentanyl, buprenorphine) still has significant constipation SEs.
oxymorphone trials begin, page-41
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |